Loury, David,Hedrick, Eric,Elias, Laurence,Mody, Tarak,Fyfe, Gwen,Buggy, Joseph
申请号：
NZ73604811
公开号：
NZ736048A
申请日:
2011.06.03
申请国别(地区):
NZ
年份:
2019
代理人:
摘要：
Described is the use of (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (ibrutinib / PCI-32765) in the manufacture of a medicament for treating relapsed or refractory follicular lymphoma in an individual in need thereof, wherein the medicament is formulated for administration of the compound once per day in an amount of about 560 mg, in a solid oral dosage form.
